PATIENT MEDICATION
ADHERENCE IN NUMBERS

  • 50% adherence rate for chronic patients
  • 70% of nonadherence is caused by behavioral reasons.
  • 125K deaths every year in the US alone.
  • $250B/yr potential revenue loss to US Pharma.
  • $300B/yr in avoidable costs to the health care system.

THE PROACTIVE HEALTH AGENT

XOLTAR revolutionizes remote patient digital interaction through an engaging live video chat between the patient and an AI agent with a human touch. XOLTAR’s unique technology combines Machine Learning algorithms together with Behavioral Science, helping patients remove barriers throughout the treatment journey.

XOLTAR’s a digital representatives can see, hear, use context and even identify non-verbal cues, enabling real-time, goal-driven, natural flowing sessions. Unlike other conversational AI solutions which lack true understanding of meaning or context, XOLTAR digital representatives/assistants/nurse can process any conversational input in real time, generate insights, and weave them naturally back into the conversation. These qualities facilitate a human-like dialogue, encouraging engagement and behavioral change in patient’s adherence at scale.

XOLTAR allows payers and pharma to assist millions of patients simultaneously and improve their quality of life.

HOW IT WORKS

FOUNDERS

Asaf Shiloni
CEO & Co-Founder

Tal Meller
CPO & Co-Founder

FOUNDING TEAM

Dr. Ariel Goldstein
NLP Researcher

Zack Hershkovich
VP R&D

Dr Alon Goldstein
Chief Behavioral Officer

Shlomo Neuberger
Full-Stack Developer

Ran Avigad
CG Architect

ADVISORY

Arnon Shafir
BD Advisor

Hanan Miron
Financial Advisor

Matteo Shapira
Experience Advisor